Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1725.57 Billion KRW | 7.38% |
| 2022 | 1607 Billion KRW | 4.68% |
| 2021 | 1535.12 Billion KRW | 16.85% |
| 2020 | 1313.71 Billion KRW | 12.97% |
| 2019 | 1162.92 Billion KRW | 22.73% |
| 2018 | 947.53 Billion KRW | 19.4% |
| 2017 | 793.6 Billion KRW | 3.21% |
| 2016 | 768.92 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1890.48 Billion KRW | 7.2% |
| 2024 Q1 | 1763.55 Billion KRW | 2.2% |
| 2023 Q1 | 1704.86 Billion KRW | 6.09% |
| 2023 FY | 1725.57 Billion KRW | 7.38% |
| 2023 Q4 | 1725.57 Billion KRW | -2.43% |
| 2023 Q3 | 1768.61 Billion KRW | 3.12% |
| 2023 Q2 | 1715.07 Billion KRW | 0.6% |
| 2022 Q2 | 1642.21 Billion KRW | 4.47% |
| 2022 Q4 | 1607 Billion KRW | -10.26% |
| 2022 Q3 | 1790.76 Billion KRW | 9.05% |
| 2022 FY | 1607 Billion KRW | 4.68% |
| 2022 Q1 | 1571.92 Billion KRW | 2.4% |
| 2021 Q3 | 1409.76 Billion KRW | 0.0% |
| 2021 Q4 | 1535.12 Billion KRW | 8.89% |
| 2021 FY | 1535.12 Billion KRW | 16.85% |
| 2020 FY | 1313.71 Billion KRW | 12.97% |
| 2019 FY | 1162.92 Billion KRW | 22.73% |
| 2018 FY | 947.53 Billion KRW | 19.4% |
| 2017 FY | 793.6 Billion KRW | 3.21% |
| 2016 FY | 768.92 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| HLB Co., Ltd. | 751.72 Billion KRW | -129.549% |
| iNtRON Biotechnology, Inc. | 98.61 Billion KRW | -1649.812% |
| BINEX Co., Ltd. | 257.01 Billion KRW | -571.398% |
| Bioneer Corporation | 315.48 Billion KRW | -446.954% |
| Anterogen.Co.,Ltd. | 149.43 Billion KRW | -1054.755% |
| MEDIPOST Co., Ltd. | 449.39 Billion KRW | -283.978% |
| CrystalGenomics, Inc. | 243.11 Billion USD | -609.774% |
| Helixmith Co., Ltd | 227.27 Billion KRW | -659.229% |
| Medy-Tox Inc. | 611.62 Billion KRW | -182.13% |
| Peptron, Inc. | 52.49 Billion KRW | -3187.053% |
| Amicogen, Inc. | 467.09 Billion KRW | -269.424% |
| Genexine, Inc. | 376.58 Billion KRW | -358.213% |
| HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | -759.37% |
| LegoChem Biosciences, Inc. | 189.5 Billion KRW | -810.581% |
| ALTEOGEN Inc. | 256.09 Billion KRW | -573.788% |
| PharmaResearch Co., Ltd. | 535.28 Billion KRW | -222.367% |
| SillaJen, Inc. | 76.71 Billion KRW | -2149.329% |
| JETEMA, Co., Ltd. | 252.14 Billion KRW | -584.351% |
| OliX Pharmaceuticals,Inc | 102.82 Billion KRW | -1578.161% |
| Genomictree Inc. | 132.84 Billion KRW | -1198.945% |
| MedPacto, Inc. | 80.47 Billion KRW | -2044.248% |
| D&D Pharmatech | 79.2 Billion KRW | -2078.65% |
| EASY BIO,Inc. | 172.04 Billion KRW | -902.996% |
| GI Innovation, Inc. | 81.34 Billion KRW | -2021.424% |